GlaxoSmithKline (GSK) has agreed to sell its nutritional drinks brands – the iconic Lucozade and Ribena – to the Japanese consumer goods firm Suntory Beverage & Food (SBF) for £1.35bn in cash. GlaxoSmithKline is to sell ...
Tags: Agriculture, Food
Experts have called for reforms of public hospitals and more legislation on the pharmaceutical industry, after police revealed more details on Tuesday of suspected financial violations by GlaxoSmithKline China. The British pharmaceutical ...
SelecTech, Inc. a leader in the manufacture of innovative residential, commercial and industrial flooring products from recycled materials, has unveiled their newest product for industrial environments, EpoxyStyle ESD. Created for ...
Tags: Floor, Construction, Decoration
Reportlinker.com announces that a new market research report is available in its catalogue: Retail cosmetics sales are affected by market trends in Poland. Report analyses distribution, consumer preferences and ranks top sellers. As ...
Tags: Cosmetics, Light Industry, Daily Use
The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's Flulaval Quadrivalent (Influenza Virus Vaccine) for the active immunization of people three years of age and more to help prevent disease caused by seasonal influenza ...
Tags: Flulaval Quadrivalent
Reports from Xinhua News Agency said that China will launch a new round of investigation lasting for three months to attack bribery in pharmaceutical and medical treatment fields. The investigation will be led by the State Administration ...
Tags: Health, Medicine, Drug Makers
China is intensifying its investigation into alleged bribery in the pharmaceutical and medical services sector with a fresh three-month probe due to begin today. The investigation by the State Administration for Industry and Commerce, a ...
Tags: milk powder, medicine pricing
The European Commission has granted additional indication for GlaxoSmithKline’s (GSK) Tyverb (lapatinib) in combination with trastuzumab for adult patients with overexpress HER2 (ErbB2), with hormone receptor-negative (HR-) metastatic ...
Tags: European Commission
ViiV Healthcare, HIV company established by GlaxoSmithKline and Pfizer, has announced the FDA approval of an integrase inhibitor, Tivicay (dolutegravir) 50mg tablets, for the treatment of HIV-1. Tivicay is indicated for use in combination ...
Tags: Viiv Healthcare, HIV-1
Pharmaceutical and healthcare company GlaxoSmithKline (GSK) will roll out two-dimensional (2D) barcodes on the inner containers as well as outer boxes for most of its US vaccines. According to the company, a 2D barcode is a small square ...
Tags: GlaxoSmithKline, 2D Barcodes
GlaxoSmithKline (GSK) has submitted an application seeking approval from the European Medicines Agency (EMA) of a variation for Votrient (pazopanib). The approval is for additional indication for Votrient as the maintenance treatment of ...
British drugmaker GlaxoSmithKline (GSK) has submitted a marketing authorisation application (MAA) to the European Medicines Agency (EMA) for its cervical cancer vaccine, Cervarix [Human papillomavirus bivalent (types 16 and 18) vaccine, ...
Tags: Cervarix, Schedule Application
The US Food and Drug Administration (FDA) has approved the supply of GlaxoSmithKline's four-strain (quadrivalent) influenza vaccine, Fluarix Quadrivalent, to CDC distribution centers and healthcare providers in the US. Fluarix ...
India has partly suspended patents granted to Roche Holding for its breast cancer drug Herceptin, over issues that the patents had not been filed in accordance with the laid down process. An article published in Swiss newspaper Schweiz am ...
Tags: Cancer Drug Patent
The Intellectual Property Appellate Board (IPAB) in India has cancelled the patent for GlaxoSmithKline's (GSK) anti-cancer drug Tykerb in its salt form over failure in demonstrating significant improvement in the efficacy. Fresenius ...
Tags: Anti-Cancer Drug